Clinical Trial: Exosome Therapy for Male Androgenetic Alopecia

U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07693244) titled 'Exosome Therapy for Male Androgenetic Alopecia' on July 06.

Brief Summary: The goal of this clinical trial is to learn if local scalp injection of human umbilical cord mesenchymal stem cell-derived exosomes (hUCMSC-Exos) can treat androgenetic alopecia (AGA) in male patients with AGA.

The main question it aims to answer is:

Does hUCMSC-Exos injection improve hair regrowth compared with placebo?

Researchers will compare hUCMSC-Exos injection to placebo injection to see if hUCMSC-Exos leads to superior efficacy in hair follicle regeneration, as measured by changes in hair density, hair thickness, and patient-reported outcomes.

Par...